Spyre Therapeutics Inc. (SYRE)
NASDAQ: SYRE
· Real-Time Price · USD
15.76
0.26 (1.68%)
At close: Jul 03, 2025, 2:54 PM
16.00
1.52%
After-hours: Jul 03, 2025, 02:54 PM EDT
1.68% (1D)
| Bid | 15.42 |
| Market Cap | 951.17M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -208.93M |
| EPS (ttm) | -3.06 |
| PE Ratio (ttm) | -5.15 |
| Forward PE | -4.69 |
| Analyst | Buy |
| Ask | 16.17 |
| Volume | 506,667 |
| Avg. Volume (20D) | 616,350 |
| Open | 15.53 |
| Previous Close | 15.50 |
| Day's Range | 15.43 - 16.44 |
| 52-Week Range | 10.91 - 40.26 |
| Beta | 2.73 |
About SYRE
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol SYRE
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for SYRE stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 weeks ago
-11.64%
SYRE stock has given up its prior gain. Spyre Ther...
Unlock content with
Pro Subscription
2 weeks ago
-11.64%
Spyre Therapeutics shares are trading higher after the company announced interim Phase 1 results from its first-in-human trials of SPY002 and SPY072.
